A “new set of leaders” emerged in the contract manufacturing organization (CMO) industry over the past year, though many remain unheard of, according to a recent report. Kate Hammeke, Vice President, Market Research, Industry Standard Research, told us drug product outsourcers are consistent in their prioritization of CMO selection attributes. “The same three attributes topped the list in 2017 as 2016,” she explained. The first three of these attributes being a “strong regulatory track record.” Other CMO performance attributes evaluated by respondents included on-time deliver, quality performance metrics, scale-up and tech transfer abilities, scientific knowledge, right-first-time measurements, among others. Continue reading: https://www.outsourcing-pharma.com/Contract-Manufacturing/CMOs-need-to-increase-awareness-of-offerings-ISR-reports

ISR CUSTOMERS